TY - JOUR
T1 - Classification of α-thalassemia data using machine learning models
AU - Christensen, Frederik
AU - Kılıç, Deniz Kenan
AU - Nielsen, Izabela Ewa
AU - El-Galaly, Tarec Christoffer
AU - Glenthøj, Andreas
AU - Helby, Jens
AU - Frederiksen, Henrik
AU - Möller, Sören
AU - Fuglkjær, Alexander Djupnes
N1 - Copyright © 2025 The Author(s). Published by Elsevier B.V. All rights reserved.
PY - 2025/3
Y1 - 2025/3
N2 - BACKGROUND: Around 7% of the global population has congenital hemoglobin disorders, with over 300,000 new cases of α-thalassemia annually. Diagnosis is costly and inaccurate in low-income regions, often relying on complete blood count (CBC) tests. This study employs machine learning (ML) to classify α-thalassemia traits based on gender and CBC, exploring the effects of grouping silent- and non-carriers.METHODS: The dataset includes 288 individuals with suspected α-thalassemia from Sri Lanka. It was classified using eleven discriminant formulae and nine ML models. Outliers were removed using Mahalanobis distance, and resampling was conducted with the synthetic minority oversampling technique (SMOTE) and SMOTE-nominal continuous (NC). The Mann-Whitney U test handled feature extraction and class grouping. ML performance was evaluated with eight criteria.RESULTS: The Ehsani formula achieved an area under the receiver operating characteristic curve (ROC-AUC) of 0.66 by grouping silent- and non-carriers. The convolutional neural network (CNN) without feature extraction demonstrated better performance, with an accuracy of 0.85, sensitivity of 0.8, specificity of 0.86, and ROC-AUC of 0.95/0.93 (micro/macro). Performance was maintained even without preprocessing.CONCLUSION: ML models outperformed classical discriminant formulae in classifying α-thalassemia using sex and CBC features. A larger dataset could enhance ML model generalization and the impact of feature extraction. Grouping silent- and non-carriers improved ML results, especially with resampling. The silent carriers were not separable from non-carriers regarding the available features.
AB - BACKGROUND: Around 7% of the global population has congenital hemoglobin disorders, with over 300,000 new cases of α-thalassemia annually. Diagnosis is costly and inaccurate in low-income regions, often relying on complete blood count (CBC) tests. This study employs machine learning (ML) to classify α-thalassemia traits based on gender and CBC, exploring the effects of grouping silent- and non-carriers.METHODS: The dataset includes 288 individuals with suspected α-thalassemia from Sri Lanka. It was classified using eleven discriminant formulae and nine ML models. Outliers were removed using Mahalanobis distance, and resampling was conducted with the synthetic minority oversampling technique (SMOTE) and SMOTE-nominal continuous (NC). The Mann-Whitney U test handled feature extraction and class grouping. ML performance was evaluated with eight criteria.RESULTS: The Ehsani formula achieved an area under the receiver operating characteristic curve (ROC-AUC) of 0.66 by grouping silent- and non-carriers. The convolutional neural network (CNN) without feature extraction demonstrated better performance, with an accuracy of 0.85, sensitivity of 0.8, specificity of 0.86, and ROC-AUC of 0.95/0.93 (micro/macro). Performance was maintained even without preprocessing.CONCLUSION: ML models outperformed classical discriminant formulae in classifying α-thalassemia using sex and CBC features. A larger dataset could enhance ML model generalization and the impact of feature extraction. Grouping silent- and non-carriers improved ML results, especially with resampling. The silent carriers were not separable from non-carriers regarding the available features.
KW - Alpha thalassemia
KW - Artificial intelligence
KW - Classification
KW - Hemoglobinopathies
KW - Machine learning
UR - https://www.scopus.com/pages/publications/85214513739
U2 - 10.1016/j.cmpb.2024.108581
DO - 10.1016/j.cmpb.2024.108581
M3 - Journal article
C2 - 39798280
SN - 0169-2607
VL - 260
JO - Computer Methods and Programs in Biomedicine
JF - Computer Methods and Programs in Biomedicine
M1 - 108581
ER -